(MENAFN- GlobeNewsWire - Nasdaq) Single Cell Genomics offers vast opportunities in healthcare R&D, with potential for new disease identification and treatment. It's transitioning from lab to clinical ...

Dublin, Dec. 18, 2025 (GLOBE NEWSWIRE) -- The "Single Cell Genomics Markets: Forecasts by Analyte, Product, Workflow, User, Application and Country with Executive and Consultant Guides" has been added ...

"Transforming Biological Research and Personalized Medicine: Single-Cell Genomics and Proteomics Show Cellular Heterogeneity, Driving Advances in Disease Mechanisms, Drug Discovery, and Precision ...

The partners are launching ImmuneScape, a multiomics program using spatial and single-cell sequencing to study immune drivers ...

10x Genomics, Inc. (NASDAQ:TXG) is one of the best digital health stocks to buy now. On October 29, 2025, 10x Genomics announced the launch of its next-generation Chromium Flex assay, designed to help ...

Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced a collaboration with Dana-Farber Cancer Institute to analyze tumor samples from patients with major solid ...

PLEASANTON, Calif. - 10x Genomics, Inc. (NASDAQ:TXG), currently trading at $12.80 with a market capitalization of $1.57 billion, announced today it has signed a definitive agreement to acquire Scale ...